Resource Hub
VIRTUAL TOUR
CONTACT US
Our Company
Investors
Services
Our Responsibility
Careers
Our Company
Investors
Services
Our Responsibility
Careers
© 2024 Aragen Bioscience. All rights reserved
Back
About Us
Our Journey
Leadership
Scientific and BD Team
Aragen Advantage
Investors
Global Locations
Media & Events
Recognitions
Disclosures under Regulation 62 of the LODR
Corporate Governance
Small Molecules
Large Molecules (Biologics)
Discovery
Aragen Integrated Drug Discovery (AIDD)
Integrated Drug Discovery
Chemistry
Biology
Safety Assessment
Development & Manufacturing
Drug Substance - new
Drug Substance
Drug Product
Analytical Development
Performance Chemicals
Custom Chemical Synthesis
Commercial Manufacturing
Discovery
Integrated Discovery
Molecular Biology
Antibody Discovery
Protein Sciences
Cell Line Development
Biology
Development & Manufacturing
Process Research & Development
Bioproduction
Developability & Analytics
GMP Manufacturing
EHS & Sustainability
Strategic Supply Chain Management
Quality
IP Protection & Data Security
Employee Welfare
Corporate Social Responsibility
Corporate Governance
Working at Aragen
Career Opportunities
Meet Our People
Caution Notice
Close Search
Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
GET IN TOUCH
Back to Resources
Whitepapers
Filter by Science
All
All
Analytical
Biologics
Biology
Chemistry
Development
Ecotoxicology
Formulations BU
Intox
Manufacturing
NBEs Intox
PCET
SAS/Toxicology
From Molecular Pharmaceutics to Scalable Manufacturing: CRDMO Expertise in Spray Dried Dispersions
Pharmacokinetic Assessment and Anti-Drug Antibodies Assessment of GLP-1 Receptor Agonists
Enhancing Biopharmaceutical Manufacturing with Single-Use Bioreactors: A Transformative Solution for CRDMO Operations
Revolutionizing new drug discovery- Harnessing AI ML Tools
Preclinical Evaluation of Vaccines and Antivirals in RSV Challenge Rodent Models
Preclinical Evaluation of new Antifibrotics in NASH-Induced Fibrosis Models
Preclinical Evaluation of new Antifibrotics in Corona mouse Virus-Induced Fibrosis Model
Preclinical Evaluation of new Antifibrotics in IPF Rodent Models
Preclinical evaluation of vaccines and antivirals in RSV challenge SCID mouse models
Preclinical evaluation of vaccines and antivirals in RSV challenge in BALB/c Mouse models
Flow Chemistry vs. Batch Processes
A Novel Cell-based Screening Assay for Cholesterol Biosynthetic Pathway Inhibition Using the RapidFire HTMS Platform
A Highly Reproducible
In Vivo
Model for Bleomycin-Induced Lung Fibrosis in Mice to Evaluate Drugs for the Treatment of Idiopathic Pulmonary Fibrosis
Pharmacokinetic Strategies in CNS Drug Discovery
Learn more about our end-to-end capabilities
×
Contact An Expert Today!
Contact Us
+
+
Back to Resources
